FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775344208> ?p ?o ?g. }

• W2775344208 abstract "Background: Diabetes mellitus is a heterogeneous chronic metabolic disorder principally characterized by persistent hyperglycemia resulting from defects in insulin action and/or insulin secretion. In course of time, prolonged hyperglycemia and associated metabolic aberrations result in tissue toxicity manifested as accelerated atherosclerosis, renoretinal microangiopathy, and neuropathy leading to a variety of vascular, neurological, and focal complications. Aim and Objective: The aim of this study is to evaluate the efficacy and safety of metformin and vildagliptin versus metformin and glimepiride in patients with Type 2 diabetes mellitus. Materials and Methods: This is a longitudinal interventional study. A total of 60 patients were enrolled in the study. Those patients who were already on metformin 500 mg bid with poor glycemic control were included in the study. These 60 patients were divided into two groups each consisting of 30 patients. Group A patients received glimepiride 1 mg bid and metformin 500 mg bid. Group B patients received vildagliptin 50 mg bid and metformin 500 mg bid. The total period of the study was 3 months. Results: After 3 months of treatment, both the groups caused a significant decline in blood glucose levels both fasting blood sugar (FBS) as well as postprandial blood sugar (PPBS) levels. There was a significant difference between the two groups in reducing the FBS levels and PPBS. Hemoglobin A1c (HbA1c) was also reduced significantly in both groups at 12 weeks. After 3 months of therapy, there was a reduction in HbA1C in B group. The reduction of HbA1C was not statistically significant between the two groups. Adverse effects were more with metformin and glimepiride group at the end of 3 months therapy. There was a significant difference in the incidence of adverse effects between both the groups. Conclusions: Vildagliptin and metformin combination provided better efficacy comparable to that of glimepiride and metformin combination and resulted in better adverse effect profile with lower risks of hypoglycemia and weight gain." @default.
• W2775344208 created "2017-12-22" @default.
• W2775344208 creator A5018446902 @default.
• W2775344208 creator A5086393641 @default.
• W2775344208 date "2017-01-01" @default.
• W2775344208 modified "2023-09-26" @default.
• W2775344208 title "Comparison of efficacy and safety of metformin and vildagliptin versus metformin and glimepiride in patients of Type 2 diabetes mellitus" @default.
• W2775344208 doi "https://doi.org/10.5455/njppp.2018.8.1143618112017" @default.
• W2775344208 hasPublicationYear "2017" @default.
• W2775344208 type Work @default.
• W2775344208 sameAs 2775344208 @default.
• W2775344208 citedByCount "0" @default.
• W2775344208 crossrefType "journal-article" @default.
• W2775344208 hasAuthorship W2775344208A5018446902 @default.
• W2775344208 hasAuthorship W2775344208A5086393641 @default.
• W2775344208 hasConcept C126322002 @default.
• W2775344208 hasConcept C134018914 @default.
• W2775344208 hasConcept C2776307423 @default.
• W2775344208 hasConcept C2776453732 @default.
• W2775344208 hasConcept C2777180221 @default.
• W2775344208 hasConcept C2777688063 @default.
• W2775344208 hasConcept C2778199505 @default.
• W2775344208 hasConcept C2779306644 @default.
• W2775344208 hasConcept C2780323712 @default.
• W2775344208 hasConcept C2780473172 @default.
• W2775344208 hasConcept C2780485761 @default.
• W2775344208 hasConcept C2780668416 @default.
• W2775344208 hasConcept C2910068830 @default.
• W2775344208 hasConcept C555293320 @default.
• W2775344208 hasConcept C71924100 @default.
• W2775344208 hasConcept C90924648 @default.
• W2775344208 hasConceptScore W2775344208C126322002 @default.
• W2775344208 hasConceptScore W2775344208C134018914 @default.
• W2775344208 hasConceptScore W2775344208C2776307423 @default.
• W2775344208 hasConceptScore W2775344208C2776453732 @default.
• W2775344208 hasConceptScore W2775344208C2777180221 @default.
• W2775344208 hasConceptScore W2775344208C2777688063 @default.
• W2775344208 hasConceptScore W2775344208C2778199505 @default.
• W2775344208 hasConceptScore W2775344208C2779306644 @default.
• W2775344208 hasConceptScore W2775344208C2780323712 @default.
• W2775344208 hasConceptScore W2775344208C2780473172 @default.
• W2775344208 hasConceptScore W2775344208C2780485761 @default.
• W2775344208 hasConceptScore W2775344208C2780668416 @default.
• W2775344208 hasConceptScore W2775344208C2910068830 @default.
• W2775344208 hasConceptScore W2775344208C555293320 @default.
• W2775344208 hasConceptScore W2775344208C71924100 @default.
• W2775344208 hasConceptScore W2775344208C90924648 @default.
• W2775344208 hasLocation W27753442081 @default.
• W2775344208 hasOpenAccess W2775344208 @default.
• W2775344208 hasPrimaryLocation W27753442081 @default.
• W2775344208 hasRelatedWork W1995045391 @default.
• W2775344208 hasRelatedWork W2023459427 @default.
• W2775344208 hasRelatedWork W2033842517 @default.
• W2775344208 hasRelatedWork W2041445139 @default.
• W2775344208 hasRelatedWork W2113355164 @default.
• W2775344208 hasRelatedWork W2121242002 @default.
• W2775344208 hasRelatedWork W2185619686 @default.
• W2775344208 hasRelatedWork W2242367764 @default.
• W2775344208 hasRelatedWork W2364128741 @default.
• W2775344208 hasRelatedWork W2391925980 @default.
• W2775344208 hasRelatedWork W2553630145 @default.
• W2775344208 hasRelatedWork W2589309406 @default.
• W2775344208 hasRelatedWork W2766340591 @default.
• W2775344208 hasRelatedWork W2810443031 @default.
• W2775344208 hasRelatedWork W2887021197 @default.
• W2775344208 hasRelatedWork W2904234460 @default.
• W2775344208 hasRelatedWork W2991751012 @default.
• W2775344208 hasRelatedWork W3127345118 @default.
• W2775344208 hasRelatedWork W1574622010 @default.
• W2775344208 hasRelatedWork W2952412574 @default.
• W2775344208 isParatext "false" @default.
• W2775344208 isRetracted "false" @default.
• W2775344208 magId "2775344208" @default.
• W2775344208 workType "article" @default.